Top

Published in:

01-12-2011 | Chest

European and North American lung cancer screening experience and implications for pulmonary nodule management

Authors: Arjun Nair, David M. Hansell

Published in: European Radiology | Issue 12/2011

Abstract

The potential for low dose computed tomography (LDCT) to act as an effective tool in screening for lung cancer is currently the subject of several randomised control trials. It has recently been given prominence by interim results released by the North American National Lung Screening Trial (NLST). Several other trials assessing LDCT as a screening tool are currently underway in Europe, and are due to report their final results in the next few years. These include the NELSON, DLSCT, DANTE, ITALUNG, MILD and LUSI trials. Although slow to instigate a trial of its own, the UK Lung Screen (UKLS) trial will shortly commence. The knowledge gained from the newer trials has mostly reinforced and refined previous concepts that have formed the basis of existing nodule management guidelines. This article takes the opportunity to summarise the main aspects and initial results of the trials presently underway, assess the status of current collaborative efforts and the scope for future collaboration, and analyse observations from these studies that may usefully inform the management of the indeterminate pulmonary nodule.

Key Points

• Low dose CT screening for lung cancer is promising.

• The effect of LDCT screening on mortality is still uncertain.

• Several European randomised controlled trials for LDCT are underway.

• The trials vary in methodology but most compare LDCT to no screening.

• Preliminary results have reinforced existing nodule management concepts.

Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781PubMedCrossRef

McMahon PM, Christiani DC (2007) Computed tomography screening for lung cancer. BMJ 334:271PubMedCrossRef

Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99–105PubMedCrossRef

Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, Hasegawa M, Yamanda T, Kubo K, Hanamura K, Asakura K (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351:1242–1245PubMedCrossRef

Pastorino U, Bellomi M, Landoni C, De FE, Arnaldi P, Picchio M, Pelosi G, Boyle P, Fazio F (2003) Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 362:593–597PubMedCrossRef

MacRedmond R, Logan PM, Lee M, Kenny D, Foley C, Costello RW (2004) Screening for lung cancer using low dose CT scanning. Thorax 59:237–241PubMedCrossRef

Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, Heindel W (2002) Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 222:773–781PubMedCrossRef

Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763–1771PubMedCrossRef

Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K (2002) Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 20:911–920PubMedCrossRef

10.

Black WC (2007) Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 110:2370–2384PubMedCrossRef

11.

Bach PB, Silvestri GA, Hanger M, Jett JR (2007) Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:69S–77SPubMedCrossRef

12.

Marshall E (2010) Cancer screening. The promise and pitfalls of a cancer breakthrough. Science 330:900–901PubMedCrossRef

13.

Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ (2011) The National Lung Screening Trial: overview and study design. Radiology 258:243–253PubMedCrossRef

14.

Aberle DR, Black WC, Goldin J, Patz E, Gareen I, Gatsonis C. American College of Radiology Imaging Network ACRIN No. 6654 Contemporary Screening for the detection of lung cancer Amendment 10. Available at http://www.acrin.org/6654_protocol.aspx. Last updated 2004. Accessed 8-4-2011

15.

MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF Jr, Swensen SJ (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237:395–400PubMedCrossRef

16.

Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF (2010) Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 102:1771–1779PubMedCrossRef

17.

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine. Massachusetts Medical Society. Available at: http://dx.doi.org/10.1056/NEJMoa1102873 . Last updated 29-6-2011. Accessed 30-6-2011

18.

Church TR (2003) Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 10:713–715PubMedCrossRef

19.

Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, Moriyama N (1996) Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 201:798–802PubMed

20.

van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ (2007) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120:868–874PubMedCrossRef

21.

Xu DM, Gietema H, de KH, Vernhout R, Nackaerts K, Prokop M, Weenink C, Lammers JW, Groen H, Oudkerk M, van KR (2006) Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 54:177–184PubMedCrossRef

22.

Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, Mandrekar JN (2007) Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 242:555–562PubMedCrossRef

23.

van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, van Iersel CA, van den Bergh KA, van’t WS, van der Aalst C, Thunnissen E, Xu DM, Wang Y, Zhao Y, Gietema HA, de Hoop BJ, Groen HJ, de Bock GH, van OP, Weenink C, Verschakelen J, Lammers JW, Timens W, Willebrand D, Vink A, Mali W, de Koning HJ (2009) Management of lung nodules detected by volume CT scanning. N Engl J Med 361:2221–2229PubMedCrossRef

24.

Yankelevitz DF, Kostis WJ, Henschke CI, Heelan RT, Libby DM, Pasmantier MW, Smith JP (2003) Overdiagnosis in chest radiographic screening for lung carcinoma: frequency. Cancer 97:1271–1275PubMedCrossRef

25.

Wang Y (2010) Methods and validation of nodule measurement in a lung cancer screening: Chapter 6: Benefit of consensus double reading during baseline lung cancer CT screening. University of Groningen, Groningen

26.

Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, Libby D, Pasmantier M, Vazquez M, Koizumi J, Flieder D, Altorki N, Miettinen OS (2001) Early lung cancer action project: initial findings on repeat screenings. Cancer 92:153–159PubMedCrossRef

27.

Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO, Allen KL (2005) CT screening for lung cancer: five-year prospective experience. Radiology 235:259–265PubMedCrossRef

28.

Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Paganelli G, Maisonneuve P, Preda L, Leo F, Bertolotti R, Solli P, Spaggiari L (2008) Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 61:340–349PubMedCrossRef

29.

Blanchon T, Brechot JM, Grenier PA, Ferretti GR, Lemarie E, Milleron B, Chague D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Remy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefebure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A (2007) Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58:50–58PubMedCrossRef

30.

Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, Thorsen H, Brodersen J, Skov BG, Dossing M, Mortensen J, Richter K, Clementsen P, Seersholm N (2009) The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol 4:608–614PubMedCrossRef

31.

Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Alloisio M, Incarbone M, Testori A, Destro A, Cappuzzo F, Roncalli M, Santoro A, Ravasi G (2008) Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 59:355–363PubMedCrossRef

32.

Lopes PA, Picozzi G, Mascalchi M, Maria CF, Carrozzi L, Comin C, Spinelli C, Falaschi F, Grazzini M, Innocenti F, Ronchi C, Paci E (2009) Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64:34–40CrossRef

33.

Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G (2009) A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 180:445–453PubMedCrossRef

34.

Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC (2008) Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 9:649–656PubMedCrossRef

35.

European Union Public Health Information System (EUPHIX): Lung Cancer Occurrence. http://www.euphix.org/object_document/o4588n27172.html. Last updated 17-12-2009. Accessed 28-5-2011

36.

Visbal AL, Williams BA, Nichols FC III, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P (2004) Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 78:209–215PubMedCrossRef

37.

Progetto MILD, Multicentric Italian Lung Detection. Available at http://www.capolmone.org/mild.htm. Last updated 2007. Accessed 8-4-2011

38.

Becker M, Delorme S, Kauczor HU (2008) LUSI: the german component of the european trial on the efficacy of multislice-CT for the early detection of lung cancer. Onkologie 31(Suppl 1):130, Abstract

39.

Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK (2011) UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66:308–313PubMedCrossRef

40.

Anglim PP, Alonzo TA, Laird-Offringa IA (2008) DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer 7:81PubMedCrossRef

41.

Cremona M, Calabro E, Randi G, De BM, Mondellini P, Verri C, Sozzi G, Pierotti MA, La VC, Pastorino U, Bongarzone I (2010) Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk. Cancer 116:1326–1335PubMedCrossRef

42.

Horvath I, Lazar Z, Gyulai N, Kollai M, Losonczy G (2009) Exhaled biomarkers in lung cancer. Eur Respir J 34:261–275PubMedCrossRef

43.

Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC (2007) Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:94S–107SPubMedCrossRef

44.

Xu DM, van der Zaag-Loonen HJ, Oudkerk M, Wang Y, Vliegenthart R, Scholten ET, Verschakelen J, Prokop M, de Koning HJ, van Klaveren RJ (2009) Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 250:264–272PubMedCrossRef

45.

Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000) Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 20:43–58PubMed

46.

Xu DM, van Klaveren RJ, de Bock GH, Leusveld A, Zhao Y, Wang Y, Vliegenthart R, de Koning HJ, Scholten ET, Verschakelen J, Prokop M, Oudkerk M (2008) Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial. Eur J Radiol 68:347–352PubMedCrossRef

47.

Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS (2002) CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 178:1053–1057PubMed

48.

Takashima S, Sone S, Li F, Maruyama Y, Hasegawa M, Kadoya M (2003) Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol 180:1255–1263PubMed

49.

Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnisen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M (2005) Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 23:3279–3287PubMedCrossRef

50.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D (2011) International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285PubMedCrossRef

51.

Godoy MC, Naidich DP (2009) Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 253:606–622PubMedCrossRef

52.

Veronesi G, Bellomi M, Veronesi U, Paganelli G, Maisonneuve P, Scanagatta P, Leo F, Pelosi G, Travaini L, Rampinelli C, Trifiro G, Sonzogni A, Spaggiari L (2007) Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg 84:959–965PubMedCrossRef

53.

Revel MP, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G (2004) Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology 231:453–458PubMedCrossRef

54.

Reeves AP, Biancardi AM, Apanasovich TV, Meyer CR, MacMahon H, van Beek EJ, Kazerooni EA, Yankelevitz D, McNitt-Gray MF, McLennan G, Armato SG III, Henschke CI, Aberle DR, Croft BY, Clarke LP (2007) The Lung Image Database Consortium (LIDC): a comparison of different size metrics for pulmonary nodule measurements. Acad Radiol 14:1475–1485PubMedCrossRef

55.

Goodman LR, Gulsun M, Washington L, Nagy PG, Piacsek KL (2006) Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. AJR Am J Roentgenol 186:989–994PubMedCrossRef

56.

Wormanns D, Kohl G, Klotz E, Marheine A, Beyer F, Heindel W, Diederich S (2004) Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility. Eur Radiol 14:86–92PubMedCrossRef

57.

Ashraf H, de HB, Shaker SB, Dirksen A, Bach KS, Hansen H, Prokop M, Pedersen JH (2010) Lung nodule volumetry: segmentation algorithms within the same software package cannot be used interchangeably. Eur Radiol 20:1878–1885PubMedCrossRef

58.

Goo JM, Tongdee T, Tongdee R, Yeo K, Hildebolt CF, Bae KT (2005) Volumetric measurement of synthetic lung nodules with multi-detector row CT: effect of various image reconstruction parameters and segmentation thresholds on measurement accuracy. Radiology 235:850–856PubMedCrossRef

59.

Honda O, Johkoh T, Sumikawa H, Inoue A, Tomiyama N, Mihara N, Fujita Y, Tsubamoto M, Yanagawa M, Daimon T, Natsag J, Nakamura H (2007) Pulmonary nodules: 3D volumetric measurement with multidetector CT–effect of intravenous contrast medium. Radiology 245:881–887PubMedCrossRef

60.

Honda O, Sumikawa H, Johkoh T, Tomiyama N, Mihara N, Inoue A, Tsubamoto M, Natsag J, Hamada S, Nakamura H (2007) Computer-assisted lung nodule volumetry from multi-detector row CT: influence of image reconstruction parameters. Eur J Radiol 62:106–113PubMedCrossRef

61.

Gavrielides MA, Kinnard LM, Myers KJ, Petrick N (2009) Noncalcified lung nodules: volumetric assessment with thoracic CT. Radiology 251:26–37PubMedCrossRef

62.

Gietema HA, Wang Y, Xu D, van Klaveren RJ, de KH, Scholten E, Verschakelen J, Kohl G, Oudkerk M, Prokop M (2006) Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. Radiology 241:251–257PubMedCrossRef

63.

Wang Y, de Bock GH, van Klaveren RJ, van OP, Tukker W, Zhao Y, Dorrius MD, Proenca RV, Post WJ, Oudkerk M (2010) Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability. Eur Radiol 20:1180–1187PubMedCrossRef

64.

Singh S, Pinsky P, Fineberg NS, Gierada DS, Garg K, Sun Y, Nath PH (2011) Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology 259(1):263–270, Epub 2011 Jan 19PubMedCrossRef

65.

Marchiano A, Calabro E, Civelli E, Di TG, Frigerio LF, Morosi C, Tafaro F, Ferri E, Sverzellati N, Camerini T, Mariani L, Lo VS, Pastorino U (2009) Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 251:919–925PubMedCrossRef

66.

Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby D, Pasmantier M, Koizumi J, Altorki N, Smith JP (2001) Early lung cancer action project: a summary of the findings on baseline screening. Oncologist 6:147–152PubMedCrossRef

67.

Gopal M, Abdullah SE, Grady JJ, Goodwin JS (2010) Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol 5:1233–1239PubMedCrossRef

Title: European and North American lung cancer screening experience and implications for pulmonary nodule management
Authors: Arjun Nair
David M. Hansell
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: European Radiology / Issue 12/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-011-2219-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

European and North American lung cancer screening experience and implications for pulmonary nodule management

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2011

Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T

Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression

Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review

Visual assessment of posterior atrophy development of a MRI rating scale

Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors

Acute appendicitis: prospective evaluation of a diagnostic algorithm integrating ultrasound and low-dose CT to reduce the need of standard CT